1(2018) World Health Organization. Cardiovascular diseases, fact sheet 2017. Updated 2017.

2(2018) National Heart, Lung, and Blood Institute. Coronary heart disease.

3Lloyd-Jones DM, Hong Y, Labarthe D, et al. (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction: The American heart association's strategic impact goal through 2020 and beyond. Circulation. 121:586-613.

4Benjamin EJ, Virani SS, Callaway CW, et al. (2018) Heart disease and stroke statistics-2018 update: A report from the American heart association. Circulation.

5Bender E (2016) Cell-based therapy: Cells on trial. Nature 540: 106-108.

6Buzhor E, Leshansky L, Blumenthal J, et al. (2014) Cell-based therapy approaches The hope for incurable diseases. Regen Med 9:649-672.

7Kalladka D, Sinden J, Pollock K, et al. (2016) Human neural stem cells in patients with chronic ischaemic stroke (PISCES): A phase 1, first-in-man study. Lancet. 388:787-796.

8Zuk PA, Zhu M, Mizuno H, et al. (2001) Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228.

9Zuk PA, Zhu M, Ashjian P, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.

10Sussman MA, Murry CE (2008) Bones of contention: Marrow-derived cells in myocardial regeneration. J Mol Cell Cardiol 44:950-953.

11Thakker R, Yang P (2014) Mesenchymal stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med 16:323.

12Rehman J, Traktuev D, Li J, et al. (2014) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298.

13Kapur SK, Katz AJ (2013) Review of the adipose derived stem cell secretome. Biochimie 95:2222-2228.

14Brown JC, Shang H, Li Y, Yang N, Patel N, Katz AJ (2017) Isolation of adipose-derived stromal vascular fraction cells using a novel point-of-care device: Cell characterization and review of the literature. Tissue Eng Part C Methods. 23:125-135.

15Harper SJ, Bates DO (2008) VEGF-A splicing: The key to anti-angiogenic therapeutics? Nat Rev Cancer 8:880-887.

16Ucuzian AA, Gassman AA, East AT, Greisler HP (2010) Molecular mediators of angiogenesis. J Burn Care Res. 31:158-175.

17Fearnley GW, Smith GA, Harrison MA, Wheatcroft SB, Tomlinson DC, Ponnambalam S (2013) Vascular endothelial growth factor-A regulation of blood vessel sprouting in health and disease. OA Biochemistry1.

18Fearnley GW, Smith GA, Abdul-Zani I, et al. (2016) VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking, and proteolysis. Biol Open 5:571-583.

19Smith GA, Fearnley GW, Harrison MA, Tomlinson DC, Wheatcroft SB, Ponnambalam S (2015) Vascular endothelial growth factors: Multitasking functionality in metabolism, health and disease. J Inherit Metab Dis. 38:753-763.

20Hendel RC, Henry TD, Rocha-Singh K, et al. (2000) Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect. Circulation 101:118-121.

21Eppler SM, Combs DL, Henry TD, et al. (2002) A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther. 72:20-32.

22Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.

23Gyongyosi M, Khorsand A, Zamini S, et al. (2005) NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: Subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study. Circulation 112: I157-1165.

24Stewart DJ, Kutryk MJ, Fitchett D, et al. (2009) VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial. Mol Ther 17:1109-1115.

25Hedman M, Hartikainen J, Syvanne M, et al. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio angiogenesis trial (KAT). Circulation. 107:2677-2683.

26Kastrup J, Jorgensen E, Fuchs S, et al. (2011) A randomized, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: The NOVA trial. EuroIntervention 6:813-818.

27Henry TD, Annex BH, McKendall GR, et al. (2003) The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107:1359-1365.

28Sato K, Wu T, Laham RJ, et al. (2001) Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 37:616-623.

29Henry TD, Rocha-Singh K, Isner JM, et al. (2001) Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J 142:872-880.

30Halvorsen YC, Wilkison WO, Gimble JM (2000) Adipose-derived stromal cells--their utility and potential in bone formation. Int J Obes Relat Metab Disord 24: 41-44.

31Kapur SK, Dos-Anjos Vilaboa S, Llull R, Katz AJ (2015) Adipose tissue and stem/progenitor cells: Discovery and development. Clin Plast Surg 42:155-167.

32Brown SA, Levi B, Lequeux C, Wong VW, Mojallal A, Longaker MT (2010) Basic science review on adipose tissue for clinicians. Plast Reconstr Surg 126:1936-1946.

33De Francesco F, Ricci G, D'Andrea F, Nicoletti GF, Ferraro GA (2015) Human adipose stem cells: From bench to bedside. Tissue Eng Part B Rev 21:572-584.

34Strem BM, Zhu M, Alfonso Z, et al. (2005) Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy 7:282-291.

35Lavoie JR, Rosu-Myles M (2013) Uncovering the secrets of mesenchymal stem cells. Biochimie 95:2212-2221.

36Planat-Benard V, Silvestre JS, Cousin B, et al. (2004) Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 109:656-663.

37Fraser JK, Schreiber R, Strem B, et al. (2006) Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med 3:33-37.

38Taimeh Z, Loughran J, Birks EJ, Bolli R (2013) Vascular endothelial growth factor in heart failure. Nat Rev Cardiol 10:519-530.

39Nakagami H, Maeda K, Morishita R, et al. (2005) Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 25:2542-2547.

40Goumans MJ, Zwijsen A, Ten Dijke P, Bailly S (2018) Bone morphogenetic proteins in vascular homeostasis and disease. Cold Spring Harb Perspect Biol 10:10.

41Schultheiss TM, Burch JB, Lassar AB (1997) A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11:451-462.

42Mohler ER,3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS (2001) Bone formation and inflammation in cardiac valves. Circulation 103:1522-1528.

43Duan X, Murata Y, Liu Y, Nicolae C, Olsen BR, Berendsen AD (2015) Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. Development 142:1984-1991.

44Street J, Lenehan B (2009) Vascular endothelial growth factor regulates osteoblast survival - evidence for an autocrine feedback mechanism. J Orthop Surg Res 4:19-799X-4-19.

45Deckers MM, van Bezooijen RL, van der Horst G, et al. (2002) Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143:1545-1553.

46Conn G, Bayne ML, Soderman DD, et al. (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci U S A 87:2628-2632.